Rhumbline Advisers Mimedx Group, Inc. Transaction History

Rhumbline Advisers

$113 Billion
Q2 2025

A detailed history of Rhumbline Advisers transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 182,858 shares of MDXG stock, worth $1.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

182,858

Previous 177,156 3.22%

Holding current value

$1.33 Million

Previous $1.35 Million 17.01%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$5.88 - $7.69 $33,527 - $43,848	5,702 Added 3.22%	182,858 $1.12 Million
Q1 2025 Apr 08, 2025	BUY	$7.54 - $9.28 $18,367 - $22,606	2,436 Added 1.39%	177,156 $1.34 Million
Q4 2024 May 29, 2025	SELL	$5.51 - $9.75 $13,422 - $23,751	-2,436 Reduced 1.38%	174,720 $1.68 Million
Q4 2024 Jan 30, 2025	SELL	$5.51 - $9.75 $9,240 - $16,350	-1,677 Reduced 0.95%	174,720 $1.68 Million
Q3 2024 Nov 12, 2024	SELL	$5.65 - $7.76 $52,454 - $72,043	-9,284 Reduced 5.0%	176,397 $1.04 Million
Q2 2024 Aug 01, 2024	SELL	$6.16 - $8.08 $22,219 - $29,144	-3,607 Reduced 1.91%	185,681 $1.29 Million
Q1 2024 May 09, 2024	BUY	$7.61 - $8.63 $20,311 - $23,033	2,669 Added 1.43%	189,288 $1.46 Million
Q4 2023 Feb 08, 2024	BUY	$5.7 - $9.14 $4,651 - $7,458	816 Added 0.44%	186,619 $1.64 Million
Q3 2023 Nov 09, 2023	BUY	$6.35 - $8.16 $39,966 - $51,359	6,294 Added 3.51%	185,803 $1.35 Million
Q2 2023 Aug 08, 2023	BUY	$3.14 - $6.61 $9,118 - $19,195	2,904 Added 1.64%	179,509 $1.19 Million
Q1 2023 May 11, 2023	BUY	$2.97 - $4.81 $17,517 - $28,369	5,898 Added 3.46%	176,605 $602,000
Q4 2022 Feb 14, 2023	BUY	$2.63 - $3.45 $5,441 - $7,138	2,069 Added 1.23%	170,707 $475,000
Q3 2022 Nov 10, 2022	BUY	$2.71 - $4.22 $18,791 - $29,261	6,934 Added 4.29%	168,638 $484,000
Q2 2022 Aug 11, 2022	BUY	$3.17 - $5.0 $131,082 - $206,755	41,351 Added 34.36%	161,704 $561,000
Q1 2022 May 12, 2022	BUY	$4.27 - $6.27 $26,687 - $39,187	6,250 Added 5.48%	120,353 $567,000
Q4 2021 Feb 10, 2022	SELL	$5.7 - $8.48 $11,012 - $16,383	-1,932 Reduced 1.67%	114,103 $689,000
Q3 2021 Nov 12, 2021	BUY	$5.52 - $15.83 $32,303 - $92,637	5,852 Added 5.31%	116,035 $703,000
Q2 2021 Aug 05, 2021	BUY	$9.02 - $12.72 $993,850 - $1.4 Million	110,183 New	110,183 $1.38 Million
Q4 2018 Jan 31, 2019	SELL	$1.15 - $6.45 $287,771 - $1.61 Million	-250,236 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$3.22 - $6.33 $7,889 - $15,508	-2,450 Reduced 0.97%	250,236 $1.55 Million
Q2 2018 Aug 06, 2018	BUY	$5.39 - $8.96 $55,684 - $92,565	10,331 Added 4.26%	252,686 $1.62 Million
Q1 2018 May 02, 2018	BUY	$6.69 - $17.96 $38,674 - $103,826	5,781 Added 2.44%	242,355 $1.69 Million
Q4 2017 Feb 09, 2018	BUY	$10.87 - $13.9 $347,698 - $444,619	31,987 Added 15.63%	236,574 $2.98 Million
Q3 2017 Nov 06, 2017	BUY	$11.86 - $17.34 $2.43 Million - $3.55 Million	204,587	204,587 $2.43 Million

Others Institutions Holding MDXG

# of Institutions

247

Shares Held

103M

Call Options Held

51.2K

Put Options Held

56.8K

View Full List

About MIMEDX GROUP, INC.

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $825M
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

More about MDXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Mimedx Group, Inc. Transaction History